Page last updated: 2024-10-31

neostigmine and Neutropenia

neostigmine has been researched along with Neutropenia in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xu, S1
Sharma, S1
Jadbabaie, F1
Breccia, M1
Girmenia, C1
Mecarocci, S1
Cartoni, C1
Carmosino, I1
Tafuri, A1
Alimena, G1

Other Studies

2 other studies available for neostigmine and Neutropenia

ArticleYear
Management of acute colonic pseudo-obstruction in a neutropenic patient.
    BMJ case reports, 2022, Jul-06, Volume: 15, Issue:7

    Topics: Aged; Colonic Pseudo-Obstruction; Colonoscopes; Humans; Male; Neostigmine; Neutropenia

2022
Ogilvie's syndrome in acute myeloid leukemia: pharmacological approach with neostigmine.
    Annals of hematology, 2001, Volume: 80, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cholinesterase I

2001